|
![]() |
|||
|
||||
OverviewManfred Georg Krukemeyer first describes magnetic drug targeting, by which is meant the focused application of drugs, e.g. the introduction of a cytostatic, and which is aimed at optimising its locally therapeutic effect. The author thus achieves a high concentration of cytostatic at the site of the tumour. The particles have to be large enough to be attracted by a magnetic field and so find their way into the tumour, where they release their active ingredient. The aim of the hypothesis formed by one of the author’s study groups was to show in a scientific experiment that in this case cytostatics coupled with iron particles [Fe3O4] can be introduced into a tumour. The focused introduction of drugs – magnetic drug targeting – results in faster arrival of the active ingredient at the target site together with a reduced quantity of active substances. For this reason magnetic drug targeting is also interesting from an economic point of view. Full Product DetailsAuthor: Manfred Georg KrukemeyerPublisher: Springer Imprint: Springer Edition: 1st ed. 2018 Weight: 0.454kg ISBN: 9783658205904ISBN 10: 3658205903 Pages: 122 Publication Date: 04 January 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsSarcomas and their Pathology.- Magnetic Drug Targeting.- Animal Testing and Patient Examination, Tumour Therapy in Humans.ReviewsAuthor InformationDr. med. Manfred Georg Krukemeyer is a specialist surgeon currently holding a senior position at a large German hospital enterprise. Tab Content 6Author Website:Countries AvailableAll regions |